Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
2021
2015
Americas
Clear all
Type of publications
NITAG documentation
(66)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Americas
(70)
Africa
(20)
Europe
(81)
South-East Asia
(2)
Western Pacific
(14)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(17)
Chile
(9)
United States of America
(41)
Diseases
COVID-19
(64)
Meningococcal disease
(6)
Diphtheria
(1)
Ebola
(1)
Hepatitis A
(1)
Human papillomavirus (HPV)
(12)
Influenza
(8)
Pneumococcal disease
(1)
Rotavirus
(4)
Typhoid
(1)
Yellow fever
(3)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Safety
(1)
Target population
Adults
(2)
All age groups
(3)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(5)
Publication date
2021
(65)
2015
(5)
2024
(1)
2023
(12)
2022
(39)
2020
(63)
2019
(6)
2018
(3)
2017
(1)
2016
(9)
2014
(5)
2013
(3)
2011
(3)
2010
(1)
2009
(1)
2008
(1)
2007
(2)
2006
(3)
2005
(1)
1997
(1)
70 results found
2021
∙
NACI
Recommendations on the use of COVID-19 Vaccines
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
2021
∙
ACIP
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021
2015
∙
ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Serogroup B Meningococcal (MenB) Vaccines in Adolescents and Young Adults (Including College Students)
2015
∙
NACI
Update on Quadrivalent Meningococcal Vaccines available in Canada
2015
∙
Jessica MacNeil
Considerations for Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk
2015
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults
2015
∙
Temitope Folaranmi, Lorry Rubin, Stacey W. Martin, Manisha Patel, Jessica MacNeil
Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register